Page last updated: 2024-10-24

celecoxib and Scleroderma, Diffuse

celecoxib has been researched along with Scleroderma, Diffuse in 1 studies

Scleroderma, Diffuse: A rapid onset form of SYSTEMIC SCLERODERMA with progressive widespread SKIN thickening over the arms, the legs and the trunk, resulting in stiffness and disability.

Research Excerpts

ExcerptRelevanceReference
"Eosinophilic fasciitis (EF) is a rare connective tissue disorder characterized by symmetrical sclerodermatous skin changes primarily affecting the extremities and histologically, by thickening of the fascia with chronic inflammatory infiltrate containing eosinophils."1.34Eosinophilic fasciitis in a 57-year-old Japanese-American woman. ( Ambrocio, DU; Uramoto, K, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambrocio, DU1
Uramoto, K1

Other Studies

1 other study available for celecoxib and Scleroderma, Diffuse

ArticleYear
Eosinophilic fasciitis in a 57-year-old Japanese-American woman.
    Hawaii medical journal, 2007, Volume: 66, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Diagnosis, Differential; Eosinophilia; Fasciitis

2007